| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
3,307,041
|
3,065,495
|
3,214,935
|
3,411,666
| | Cost of Revenue | 2,569,189 | 2,421,972 | 2,477,447 | 2,572,258 | | |
Gross Profit
|
737,852
|
643,523
|
737,488
|
839,408
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 379,690 | 381,100 | 381,122 | 386,681 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
358,162
|
262,423
|
356,366
|
452,727
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 3,439 | 24,422 | 3,201 | (3,901) |
|
Earnings Before Interest And Taxes | 361,601 | 286,845 | 359,567 | 448,826 |
|
Interest Expense | 23,050 | 24,216 | 23,509 | 23,487 |
|
Income Before Tax | 338,551 | 262,629 | 336,058 | 425,339 |
|
Income Tax Expense | 81,959 | 81,515 | 96,110 | 123,037 |
|
Minority Interest | (32) | (152) | (207) | (337) |
|
|
|
Net Income From Continuing Ops | 256,560 | 180,962 | 239,741 | 301,965 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
256,560
|
180,962
|
239,741
|
301,965
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
256,560
|
180,962
|
239,741
|
301,965
|
|
0.12%